Giles Coghlan

Giles Coghlan

As a professional market analyst and commentator, Giles' goal is simple: to explain the current reason markets are moving the way they are so you that can make better trading decisions right now. His cutting-edge analysis has been featured in Reuters, Business Insider, WSJ, Financial Times Adviser, NBC, LBC Radio, CoinTelegraph, Guardian Observer, National Express, and numerous other prestigious financial outlets.

Platinum play?

Platinum tends to see gains around the start of the year as Industrial purchases are made for the year from 2022. Yes, global growth concerns have been growing, but many company orders for 2023 would have already been made and…

Time for a bite of the Apple?

Apple has fallen around 20% from it’s highs, and earnings are due out on Thursday.   Apple has a few tricks it is trying right now to grab consumers attention.  Apple is working on a cheaper mixed reality headset and introduced the…

Tesla’s Time to Turn?

Since the high of 2021 Tesla’s share price has dropped over 60% as investors fled rate sensitive tech companies on expectations of tougher financial conditions ahead.  The question now is, ‘will the US manage a soft landing’ and potentially be able…

Can IBM find support from earnings?

The International Business Machines Corporation is an American multinational company operating in over 175 countries with its headquarters in New York.  It’s the seventh largest technology company by revenue. Recently Morgan Stanley downgraded the stock from an overweight rating to equal…

Is Bayer a buy?

Bayer AG shares surged higher on Tuesday this week on news that the German company forecast its peak sale of pharmaceuticals to €12 billion. Bayer forecast that its thrombosis treatment asundexian could bring in more than €5 billion. Revenue from…